Improve walking mobility using exoskeleton
- Trial ID
- NCT06028529
- Official Title
- Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
- Goal
- Improve walking mobility using exoskeleton
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- VA Office of Research and Development
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson's Disease
- Interventions
- Exoskeleton
Plain-Language Summary
Goal: to see if a portable robotic exoskeleton can be worn safely and help people with Parkinson's improve walking, balance, and overall mobility. Approach: participants wear a wearable device (Keeogo) that actively assists hip and knee flexion and extension during walking, reducing effort and stabilizing steps, and it augments movement without changing Parkinson's medications like levodopa. Eligibility: veterans aged 18 to 90 with Parkinson's confirmed by a PADRECC specialist, modified Hoehn and Yahr stage II to V, who can attend visits at the Richmond VA and pass basic strength and walking screens. Key exclusions include severe heart or lung disease, significant dementia (MoCA under 17), very low bone density, lower limb amputation, certain implants, or body size outside 5'1",6'3" and over 250 pounds.
Locations
- Richmond VA Medical Center, Richmond, VA, Richmond, Virginia, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Exoskeleton. Goal: to see if a portable robotic exoskeleton can be worn safely and help people with Parkinson's improve walking, balance, and overall mobility. Approach: participants wear a wearable device (Keeogo) that actively assists hip and knee flexion and extension during walking, reducing effort and stabilizing steps, and it augments movement without changing Parkinson's medications like levodopa. Eligibility: veterans aged 18 to 90 with Parkinson's confirmed by a PADRECC specialist, modified Hoehn and Yahr stage II to V, who can attend visits at the Richmond VA and pass basic strength and walking screens. Key exclusions include severe heart or lung disease, significant dementia (MoCA under 17), very low bone density, lower limb amputation, certain implants, or body size outside 5'1",6'3" and over 250 pounds.
- Who can participate?
- Participants must be between 18 Years and 90 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.